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Abstract: Boron nitride (BN) nanomaterials have been increasingly explored for potential applications
in chemistry and biology fields (e.g., biomedical, pharmaceutical, and energy industries) due to their
unique physico-chemical properties. However, their safe utilization requires a profound knowledge
on their potential toxicological and environmental impact. To date, BN nanoparticles have been
considered to have a high biocompatibility degree, but in some cases, contradictory results on their
potential toxicity have been reported. Therefore, in the present study, we assessed two commercial
2D BN samples, namely BN-nanopowder (BN-PW) and BN-nanoplatelet (BN-PL), with the objective
to identify whether distinct physico-chemical features may have an influence on the biological
responses of exposed cellular models. Morphological, structural, and composition analyses showed
that the most remarkable difference between both commercial samples was the diameter of their
disk-like shape, which was of 200–300 nm for BN-PL and 100–150 nm for BN-PW. Their potential
toxicity was investigated using adenocarcinomic human alveolar basal epithelial cells (A549 cells)
and the unicellular fungus Saccharomyces cerevisiae, as human and environmental eukaryotic models
respectively, employing in vitro assays. In both cases, cellular viability assays and reactive oxygen
species (ROS) determinations where performed. The impact of the selected nanomaterials in the
viability of both unicellular models was very low, with only a slight reduction of S. cerevisiae colony
forming units being observed after a long exposure period (24 h) to high concentrations (800 mg/L)
of both nanomaterials. Similarly, BN-PW and BN-PL showed a low capacity to induce the formation
of reactive oxygen species in the studied conditions. Even at the highest concentration and exposure
times, no major cytotoxicity indicators were observed in human cells and yeast. The results obtained
in the present study provide novel insights into the safety of 2D BN nanomaterials, indicating no
significant differences in the toxicological potential of similar commercial products with a distinct
lateral size, which showed to be safe products in the concentrations and exposure conditions tested.
Keywords: 2D boron nitride; eukaryotic model; nanotoxicity; cell viability; oxidative stress
1. Introduction
In recent years, the progress of nanotechnology has fueled the design and manu-
facturing of novel engineered nanomaterials (ENMs). In particular, different types of
nanomaterials have been investigated for a wide range of potential applications [1–4].
Amongst them, low dimensional boron nitride (BN) materials, have attracted the atten-
tion of the scientific community due to their promising properties, such as high thermal
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conductivity, wide optical bandgap, strong ultraviolet emission, great mechanical stiff-
ness, thermal stability, and chemical inertness [5–7]. BN consists of an equal number of
boron and nitrogen atoms, which are arranged differently depending on pressure and
temperature conditions, giving rise to distinct crystalline forms (hexagonal, rhombohedral,
diamond-like cubic, and wurtzite). BN has been widely used in industrial applications
for insulation, lubrication, fabrication of electronic parts, microwave-transparent objects,
etc. [8,9]. The material is generally considered safe, being extensively used as well in the
cosmetics industry, although not in its nanomaterial form [10,11]. More recently, BN-based
nanomaterials have also raised the attention of the scientific community for their possible
use in pharmaceutical and medical applications, such as cosmetics, drug delivery, scaffold
materials for tissue engineering, and regenerative medicine, etc. [12]. As a consequence
of the growth in the variety of applications of these nanomaterials, the increase of en-
vironmental and human exposure will be also higher, and may occur through multiple
different pathways, which makes it necessary to study their potential toxicological effects.
The availability of data on environmentally relevant concentrations (ERCs) of ENMs is
mostly the result of estimations through exposure modeling [13]. So far, specific values for
environmentally relevant concentrations of boron nitride nanoparticles have not been made
available, while predicted ERCs for other frequently used ENMs in air, water, and soil,
range from parts per trillion (ng/L or ng/kg) to parts per billion (µg/L or µg/kg) [14,15].
However, the toxicological testing of nanomaterials usually employs exposure conditions at
higher concentrations (mg/L), which could be expected in exceptional scenarios (e.g., spills,
uncontrolled waste discharges, etc.), and where toxicological responses are observable [16].
Several studies evaluating the toxicity of different BN nanoforms through in vitro,
in vivo, and in silico approaches provide valuable hints on their safety [17–21]. However,
the potential toxicity of distinct nanomaterial forms is still inadequately comprehended,
with conflicting results reported in the scientific literature. Good biocompatibility has
been reported for BN nanotubes, when exposed to HEK-293 human cells and freshwater
planarians [21,22], while hollow BN nanospheres are able to induce apoptosis and inhibit
the proliferation for both the androgen-sensitive LNCap and androgen-independent DU145
prostate cancer cells [23]. With regards to 2D BN nanomaterials, there is no clear consensus
for their biocompatibility so far, but it seems to be dependent on cell type, dosage, and
aspect ratio [12]. For instance, BN with a sheet-like structure produced adverse effects
on human hepatoma HepG2 cells, decreasing cellular viability, enhancing intracellular
ROS production, inducing adverse effects in mitochondrial depolarization, and membrane
integrity has been recently reported [24]. Similarly, BN nanosheets changed from non-
toxic to toxic towards SaOS2 cells when their diameters were reduced from the micro to
nanometer range [25]. In a more recent study, in vivo and in vitro studies employing insect
haemocytes, L929 mouse cells, and human erythrocytes showed that hexagonal BN (h-BN)
nanosheets that functionalized with hydroxyl groups had low cytotoxicity, although the
behavior of the insect immunocompetent cells was found to be altered [10].
The study of pristine and functionalized BN nanostructures as potential antimicrobial
agents, through in vitro and in silico experimental approaches, have recently attracted
the interest of researchers as well [17,26,27], aiming to develop polymer based biomedical
devices protected against bacterial proliferation. 2D BN nanoparticles incorporated in
polyhydroxybutyrate chitosan matrixes behaved as antibacterial agents against multi drug
resistant Escherichia coli and Staphylococcus aureus strains, while showing good biocompati-
bility towards immortalized human keratinocytes (HaCaT) cell lines [28]. Similarly, BN
flakes present in extruded low density polyethylene polymers displayed a bactericidal
effect when evaluated against E. coli, S. aureus, Staphylococcus epidermidis, and Pseudomonas
aeruginosa, strains [29]. Experimental and theoretical approaches employing transmission
electron microscopy and molecular dynamics simulations suggest that the hydrophobicity
of BN nanosheets can play a relevant role in damaging both bacterial outer and inner mem-
branes [17]. In this regard, the ability of BN nanosheets to exert an antifungal effect is less
known. A recent work that investigated the activity of h-BN nanoparticles against different
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bacterial species and Candida sp. M25 reported a low minimum inhibitory concentration
and antibiofilm capacity towards the yeast strain [30]. However, BN spherical nanoparti-
cles films composed by nanosheets and nanoneedles did not show an antifungal capacity
against spores of distinct Neurospora crassa strains [27]. The little information available
on the antimicrobial properties of BN nanomaterials is also an indicator of the limited
knowledge that has been generated in relation to their potential environmental impact.
Therefore, the objectives of the present work are (i) to generate new knowledge on the
potential toxicity (e.g., as a potential inhalation target) and biocompatibility of 2D BN nano-
materials in humans, by using an in vitro model of widespread use such adenocarcinomic
human alveolar basal epithelial cells (A549) [31], and (ii) to understand the environmental
hazard of the selected nanomaterials towards the well-established ecotoxicological model
Saccharomyces cerevisiae [32], providing as well novel insights into the potential antifungal
properties of BN nanoforms.
2. Results and Discussion
2.1. Selection and Characterization of Commercial Boron Nitride
In the present study, commercial BN nanopowder (BN-PW) and nanoplatelets (BN-PL)
supplied by Sigma-Aldrich® (Merck KGaA, Darmstadt, Germany) were selected. The char-
acterization information provided by the supplier indicates an average particle size of
<150 nm for BN-PW and a lateral size dimension of <1 micron for BN-PL. Many methodolo-
gies have been used by different authors to characterize the physico-chemical properties of
nanomaterials, such as composition (e.g., ICP-MS, XPS, etc.), surface chemistry and atomic
structure (XPS, Raman, etc.), charge (z-potential), size (SEM, TEM, dynamic light scatter-
ing, etc.), and morphology (AFM, SEM, TEM, etc.), aiming to understand their potential
hazard when interacting with biological systems. To confirm the provider information
and to further analyze the physico-chemical properties of the selected nanomaterials, a
number of determinations using several of these methodologies were employed in the
present study, and the obtained results have been described in Sections 2.1 and 2.2 of this
manuscript. To obtain insights into the products form and size, they were subjected to
atomic force microscopy (AFM), field-emission scanning electron microscopy (FE-SEM),
and transmission electron microscopy (TEM) analyses. As can be observed in Figure 1,
AFM analyses confirmed the presence of particles populations and aggregates with a round
shape, and a diameter in the nanoscale range for both BN products. Representative FE-SEM
images (Figure 2) of the platelets and powders at two different magnifications revealed that
the nanoparticles in both materials have a comparable disk-like geometry, while TEM im-
ages (Figure 3) confirmed that BN-PW and BN-PL have a 2D platelet-like shape. The main
difference among the two samples at the morphological level was related to the diameter
of the disk-like particles, which was observed to be of the order of 200–300 nm for BN-PL
and 100–150 nm for BN-PW.
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Figure 1. AFM images of BN nanopowder (a) and BN nanoplatelets (b). BN samples dispersions 
with a concentration of 20 mg/L were deposited by drop casting on a mica surface. 
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Figure 3. TEM images of BN nanopowder (a) and BN nanoplatelets (b). BN dispersions with a 
concentration of 20 mg/L were deposited by drop casting on carbon-coated copper grids. 
Additional insights into the diameter of the nanomaterials in different aqueous sus-
pensions (water, human cells nanomaterials exposure media (DMEM 1% FCS), and S. cere-
visiae cells culture media (YPD)) were obtained by determining their hydrodynamic size 
through dynamic light scattering (DLS). Both nanomaterials showed comparable average 
sizes (< 500 nm) in all solvents tested, which indicates a low nanoparticle aggregation 
when resuspended in aqueous solutions with a significant concentration of soluble so-
lutes, such as DMEM 1% FCS and YPD. The size distribution of the nanomaterials deter-
mined in the different aqueous suspensions is available as Supplementary Material (Fig-
ure S1). 
Another relevant characteristic of nanoparticles when present in aqueous suspen-
sions is their colloidal stability. The zeta potential is a key indicator of the stability of col-
loidal dispersions, so it was determined for BN-PW and BN-PL. As expected, both nano-
materials showed a better stability in water suspensions than when resuspended in hu-
man cells culture media and yeast cells culture media, which correlated well with the 
charges respectively determined for them in water (−35.3 mV ± 0.5 and −32.1 mV ± 0.5), 
DMEM 1% FCS (−10.0 mV ± 0.9 and −9.3 mV ± 0.6), and YPD (−14.7 mV ± 1.3 and −13.4 
mV ± 1.7). The values obtained were similar to those previously reported for 2D BN and 
other bidimensional nanomaterials [33]. 
2.2. XPS and RAMAN Analysis 
To analyze the surface chemistry (stoichiometry) and the atomic structure of the ma-
terials, XP and Raman spectra were collected and analyzed. Figure 4 shows the B1s and 
N1s XP spectra of BN-PW (black line) and BN-PL (red line) samples. For both samples, 
the B1s peak was found to be centered at 190.6 ± 0.1 eV, while the N1s peak was located 
at 398.1 ± 0.1 eV. These results are in concordance with the reported binding energies of 
hexagonal BN (h-BN) [34]. The atomic concentrations (%) of boron and nitrogen atoms in 
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Additional insights into the diameter of the nanomaterials in different aqueous suspen-
sions (water, human cells nanomaterials exposure media (DME 1% FCS), and S. cerevisiae
cells culture media (YPD)) were obtained by determining their hydrodynamic size through
dynamic light scattering (DLS). Both nanomaterials showed comparable average sizes
(<500 nm) i all solvents tested, which indicates a low nanoparticle aggregation whe
resusp nded i aqueous solutions with a significant con e tration of soluble solutes, such
as DMEM 1% FCS and YPD. The size distribution of the nanomaterials determined in the
d ff rent aqueous suspensi ns i available as Supp em ntary Material (Figure S1).
Another relevant characteristic of nanoparticles when present in aqueous suspen-
sions is t ir colloidal st bility. The zet potential is a key indicator of the stability of
c lloidal dispersions, so it was d termined for BN-PW a BN-PL. As expec ed, b th
nanomaterials showed a bett r stability in water suspensions than when r suspended in
human cells culture media and yeast cells cultur media, which correlated well w th the
charg s respectively determined for them in water (−35.3 mV ± 0.5 and −32.1 mV ± 0.5),
DMEM 1% FCS (−10.0 mV ± 0.9 and −9.3 mV ± 0.6), and YPD (−14.7 mV ± 1.3 and
−13.4 mV ± 1.7). The values obtai ed were similar to those previously reported for 2D BN
and other bidimensional nanomaterials [33].
2.2. XPS and RAMAN Analysis
To alyze the surface chemistry (stoichiometry) and the atomic structure of the
materials, XP and Raman spectra were collected and analyzed. Figure 4 shows the B1s and
N1s XP spectra of BN-PW (black line) and BN-PL (red line) samples. For both samples,
the B1s peak was found to be centered at 190.6 ± 0.1 eV, while the N1s peak was located
at 398.1 ± 0.1 eV. These results are in concordance with the reported binding energies of
hexagonal BN (h-BN) [34]. The atomic concentrations (%) of boron and nitrogen atoms
in BN-PW (B: 51.00 ± 0.05; N: 49.00 ± 0.05) and BN-PL (B: 52.29 ± 0.06; N: 47.71 ± 0.06)
corresponded as well to those expected for BN materials.
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The Raman spectra shown in Figure 5 also demonstrated the existence of the h-BN
crystal phase. Fitting the spectra w th Lorentzian lines rev aled that the E2g mode was
loca ed at 1367.5 a d 1367.7 cm−1 for the BN-PL (blue line) and BN-PW (red line), r spec-
tively. Their half wi th at half aximum were 12.7 (BN-PL 14.7 cm−1 (BN-PW). Based
on a corr lation by Nemanich et al. [35], among the crystallite sizes and the Raman shift
a d width of the E2g mode (t mode frequency s ifted to higher nergies and the width
i creased as the crystallite size decreased), the bandwidths of both BN samples indicate a
slightly smaller for BN-PW which was in concordance to the observations
in the performed microscopy analyses. Regarding the thickness dependence of the Raman
spectra, it was first studied by Gorbach v et al. [36] who r ported that the E2g band of
atomically thin BN flakes on Si/SiO2 substrates shifts ith thickn ss. The BN monolayer
exhibited a blue-shift of the order of 2–4 cm−1, whereas for mor layers a red-shift was
observe by 1–2 cm−1, in relation t the E2g energy of the bulk h-BN. Contrasting results
were reported by Li et al. [37], who found that the mono- and few-layer h-BN mechanically
exfoliated flakes exhibit systematically a blue shift in the E2g mode in comparison to the
bulk energy. More recently, Cai et al. [38] found that in the absence of interactions with
the substrate, mono- and few-layer BN flakes show no measurable shift in relation to the
compound bulk for , suggesting that the observed Raman shift in related studies arises
from the strain induced by the substrate. Based on these findings, and considering that the
BN particles employed in the present study are not free standing, it can be concluded that
the observed shift in BN-PW and BN-PL might be indicative of three-layers particles.
2.3. Toxicology Assessment Using Adenocarcinoma A549 Human Cells
To assess the potential cytotoxic effects of commercial BN nanoforms, the human
lung carcinoma cell line (A549) was selected as a cellular model, to study possible adverse
effects in human health via the inhalation exposure of nanoparticles [39]. To determine the
percentage of living cells after the BN exposure, the Neutral Red assay (one of the viability
tests most widely used in nanotoxicological studies) was performed [40]. Therefore, cells
were exposed to different concentrations (20, 40, 80, 160 mg/L) of both commercial BN-PW
and BN-PL samples for a period of 24 h. As shown in Figure 6, after the A549 cells exposure
to BN-PW and BN-PL, the viability of the cells was not reduced in the presence of any of
the concentrations tested, indicating the absence of cytotoxicity in the employed conditions.
Although BN nanomaterials are generally considered highly biocompatible [12], recent
reports suggest that the toxicity of 2D BN depends on the cell type exposed, dosage, and
nanomaterial aspect ratio. For instance, Liu et al. observed that human hepatoma HepG2
cells viability was significantly reduced in the presence of 30 mg/L BN sheet-like structured
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nanoparticles [24], while BN nanosheets changed from non-toxic to toxic towards SaOS2
cells when their diameter was reduced from the micro to nanometer range [25]. In a
more recent study, in vivo and in vitro studies employing insect haemocytes, L929 mouse
cells, and human erythrocytes showed that h-BN nanosheets functionalized with hydroxyl
groups had low cytotoxicity, although the behavior of the insect immunocompetent cells
was found to be altered [10].
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types can induce significant levels of reactive oxygen species (ROS), resulting in the cells’
inability to preserve normal physiological redox-regulated functions [42]. Due to their
high oxidation potential, the overproduction of intracellular ROS can result in the damage
of biomolecules and organelles, leading to necrosis, apoptosis, or even mutagenesis [42].
Therefore, to understand the possible presence of adverse effects at the sublethal level,
we investigated the possible intracellular increase of ROS in cells exposed to the selected
nanomaterials. As displayed in Figure 7, A549 cells were exposed to 20 and 40 mg/L
of BN-PW and BN-PL for 1 h incubation, and the obtained results showed no ROS over
production under the studied conditions.
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Figure 7. Determination of reactive oxygen species (ROS) levels in A549 cells exposed to 20 and
40 mg/L of BN-PW and BN-PL. “C” corresponds to non-exposed cells. Two independent experiments,
employing three technical replicates per exposure condition tested, were performed. One-way
ANOVA followed by the Dunnett post hoc test was done to compare every mean with that of the
control, and considered significant at p ≤ 0.05. The figure including the positive control condition
(H2O2 (20 µM)) is available as Supplementary Material (Figure S2).
Data available on oxidative stress induced by BN nanosheets in human cells is scarce,
and the reported results are conflicting or difficult to compare. BN nanosheets, in the
concentration range of 10–50 mg/L, did not induce ROS production in osteoblast cells
exposed for 24 h [43]. However, in a more recent study, Mateti et al. reported a possible
increase of ROS levels in osteoblast-like cells (SaOS2) exposed to BN nanosheets, although
the nanomaterials concentration used was remarkably higher (1000 mg/L) [25]. Sheet-like
BN nanoparticles also induced ROS formation in human hepatoma HepG2 cells exposed
to relatively low concentrations (2–20 mg/L) [24]. Similarly, in a more recent study, DU145
and PNT1A prostate cells were exposed to 22 to 176 mg/L of BN nanoparticles, and an
increase in ROS levels was observed in all cases [44].
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2.4. Toxicology Assessment Using Saccharomyces Cerevisiae
The yeast S. cerevisiae is an extensively used eukaryotic model to comprehend funda-
mental molecular mechanisms and biological processes, which is also used as a tool for the
toxicological evaluation of substances, such as pesticides, amongst other persistent and mo-
bile chemicals, or ENMs [45,46]. Therefore, to evaluate the potential environmental impact
of BN, yeast cells were exposed to two different concentrations of BN-PW and BN-PL (160
and 800 mg/L) at two exposure times (2 and 24 h), and subsequently their viability was
assessed through colony forming units (CFUs) determination. As shown in Figure 8, only
a small decrease on the cells’ viability was observed in the studied conditions after 24 h
exposure. Although the antimicrobial properties of BN nanosheets has been previously
explored, most of the studies performed have focused on bacteria, and data available on
their antifungal potential is very low. A study performed by Kıvanç et al. reported a MIC
value of h-BN nanoparticles against the yeast Candida sp. M25 of 3.25 mg/L [30]. This result
contrasts with our observations, as S. cerevisiae cells proliferation was only slightly reduced,
even in the presence of 800 mg/L of the nanomaterial. Further comparative analyses,
employing the same exposure conditions and viability assays would be necessary to un-
derstand whether the differences observed between the studies are related to specificities
from both yeast species, such as a distinct cell wall composition. In a recent study, pristine
BN films composed by spherical nanoparticles formed by nanosheets and nanoneedles did
not show an antifungal capacity against Neurospora crassa spores from different strains [27].
More studies are necessary to clarify the potential toxicity of BN nanomaterials against
different fungal species.
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As mentioned above, the evaluation of the potential induction of ROS by ENMs is
a standard toxicology assay that provides insights into possible cell damage, which can
trigger cell death and apoptosis. The accumulation of ROS in yeast usually originates
from internal metabolic processes connected to cell respiration, however, it can be similarly
induced by environmental stress stimuli, such as nanoparticles exposure [47,48]. In yeast
species, including S. cerevisiae, the consequences of ROS accumulation are programmed
cell death, autophagy, necrosis, and upregulation of antioxidants mediated by complex
transcriptional changes [49]. Therefore, to evaluate whether BN-PW and BN-PL were
able to induce oxidative stress in S. cerevisiae, cells growing at the exponential phase
were exposed to BN dispersion with a concentration of 160 and 800 mg/L for 2 and 24 h.
As shown in Figure 9, the oxidative stress levels of yeast cells exposed for 2 h to BN-PW
and BN-PL were slightly higher than those observed in the negative control. Specifically,
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the fluorescence signal increased 0.2 and 0.4 times more in the BN-PW and BN-PL samples
present at the higher concentration (800 mg/L). However, ROS levels of yeast cells exposed
to both nanomaterials for 24 h were not significantly different than those that could be
observed in the negative control condition (non-exposed cells). The early ROS induction
caused by the presence of BN-PW and BN-PL was lower than that induced by other 2D
nanomaterials, such as graphene oxide and molybdenum disulphide, when yeast cells
were exposed to them in comparable conditions [41,50].
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2 and 24 h. The reported values are expressed in arbitrary units and correspond to the averages of two independent
experiments (±standard deviation, SD), employing three technical replicates per exposure condition tested in each case.
Differences were established using a one-way ANOVA followed by the Dunnett post hoc test to compare every mean with
the control, and considered significant at p ≤ 0.05. * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001. The figure including the positive
control condition (H2O2 (10 mM)) is available as Supplementary Material (Figure S3).
3. Materials and Methods
3.1. Materials and Reagents
Chemicals employed were supplied by Sigma-Aldrich® (Merck KGaA, Darmstadt,
Germany) and Acros Organics (Thermo Fisher Scientific Inc., Madrid, Spain). BN nanopow-
der (BN-PW; ref 790532) and nanoplatelets (BN-PL; ref 900405) were purchased at Sigma-
Aldrich® (Merck KGaA, Darmstadt, Germany).
3.2. Atomic Force Microscopy
To perform and evaluate the AFM analysis, all the BN samples were dropped on a
mica surface from aqueous suspensions. Images were recorded in tapping mode (set point
of 500, 72 mV; drive amplitude 791.16; drive frequency 268.639), using silicon cantilevers
AC160TS-R3 (aluminum reflex coating and tip radius <10 nm; Olympus, Japan), with
a CYPHER ES instrument from Asylum Research (Oxford Instruments, Santa Barbara,
California, USA). IGOR Pro 6.2 was used for data acquisition and control, while images
analysis was done with ARgyle. The AFM analysis was performed at the laboratory of
instrumental techniques unit service from the University of Valladolid.
Int. J. Mol. Sci. 2021, 22, 567 11 of 15
3.3. Raman Analysis
The Raman analysis was done using an Ar ion laser (514.5 nm) in a focusing area of
2–3 µm. The scattered light was analyzed using a T-64000 (Jobin-Yvon, France) spectrometer
(spectral resolution of ~2.0 cm−1). The Raman mode of Si single crystal at 520 cm−1 was
used to calibrate the wavenumber scale of the spectra.
3.4. X-ray Photoelectron Spectroscopy
A SPECS Phoibos 100-1D-DLD and a non-monochromatized dual-anode Mg/Al X-ray
source for XPS, contained within a UHV chamber (P ~ 5 × 10−10 mbar), were used to
obtain XP spectra (MgKa at 1253.6 eV photon energy; analyzer pass energy 10 eV, FWHM of
0.85 eV for Ag3d5/2 line). The analyzed area was a rectangle of 4 × 20 mm2. The SpecsLab
Prodigy software was used to collect and analyze the spectra. XPS peaks intensity, weighted
with the corresponding RSF, were used to calculate atomic ratios.
3.5. Electron Microscopies
The high-resolution field-emission scanning electron microscope (FE-SEM) instrument
(SUPRA 35VP, Zeiss, Germany) operating at 10 kV, and transmission electron microscope
(TEM) analysis using a JEOL JEM-1011 high-resolution (HR) TEM coupled with a Gatan
Erlangshen ES1000 W camera, were employed to investigate the texture and morphology
of the commercially purchased BN nano-powders and nano-platelets were investigated.
The TEM analysis was performed at the advanced microscopy unit service from the
University of Valladolid.
3.6. Dynamic Light Scattering
Size determinations by dynamic light scattering (DLS) were done at Nanovex Biotech-
nologies S.L., employing the maximum nanoparticles concentrations used to expose human
and yeast cells, using a Zetasizer ZS90 (Marlvern Instruments Ltd., UK).
3.7. Zeta-Potential Determination
Zeta-potential analyses were performed at Nanovex Biotechnologies S.L., by the
mixed measurement mode phase analysis (M3-PALS) at room temperature, employing
the maximum nanoparticles concentrations used to expose human and yeast cells, using a
Zetasizer ZS90 (Marlvern Instruments Ltd., UK).
3.8. Assays in A549 Cells
The human alveolar carcinoma epithelial cell line A549 (ATCC, CCL-185) was cultured
and maintained in a DMEM medium (Dulbecco’s Modified Eagle Medium), supplemented
with 10% fetal calf serum (FCS) and 1% penicillin/streptomycin in a humidified incubator
at 37 ◦C, in the presence of 5% CO2.
3.8.1. A549 Cells Neutral Red Assay
Approximately 3 × 104 cells per well were seeded in 96-well plates and exposed to 20,
40, 80, and 160 mg/L of the BN materials previously diluted in DMEM 1% FCS. After 24 h
of incubation with nanomaterials, cells were washed with DPBS (Dulbecco’s Phosphate
Buffered Saline) and the Neutral Red assay was performed as previously described [41].
Fluorescence measurements were recorded using a microplate reader (BioTek Synergy
HT, Winooski, Vermont, USA), with an excitation wavelength of 530/25, and an emission
wavelength of 645/40.
3.8.2. A549 Cells ROS Determination
The DCFH-DA dye was used to quantify intracellular ROS levels. Seeded A549 cells in
a 96-micro-well plate (around 3 × 104 cells per well) were labelled, protected from the light,
with 50 µM DCFH-DA in HBSS for 30 min. Subsequently, cells were washed with HBSS,
and exposed for 1 h to the BN nanomaterials, previously diluted as well in HBSS (final
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concentrations: 20 and 40 mg/L). A BioTek Synergy HT (BioTek, Winooski, Vermont, USA)
microplate reader was used to obtain fluorescence measurements (excitation wavelength,
530/25; emission wavelength, 645/40).
3.9. Yeast Culture
The S. cerevisiae BY4741 strain was grown at 30 ◦C, and maintained in a standard
liquid and solid YPD medium (1% yeast extract, 1% yeast bacto-peptone, 2% glucose).
3.9.1. Yeast Colony Forming Units (CFUs) Determination
S. cerevisiae cells were pre-grown on an YPD medium in an orbital shaker (30 ◦C and
185 rpm) until an OD 600 nm = 1 was reached, and then they were exposed to 160 or
800 mg/L of either BN-PL or BN-PW in the same medium culture, or cultured non exposed
(negative control), in 24-well plates (final volume of 1 mL). Subsequently, culture samples
were obtained after 2 and 24 h of exposure to the nanomaterials. To determine CFUs at
both sampling times, 100 µL of cells were diluted 104 times, in the case of 2 h exposure,
and 105 times, in the case of 24 h exposure, inoculated on a solid YPD medium (6% agar)
plates, and incubated at 30 ◦C for 48 h.
3.9.2. Yeast ROS Assay
The CM-H2DCFDA dye was used to quantify intracellular ROS levels in yeast, em-
ploying a protocol similar to that previously described by James et al. (2015) [51], recently
adapted by our research group [41]. In short, cells were incubated with CM-H2DCFDA
(7 µM) in DPBS at 30 ◦C and 185 rpm for 60 min, subsequently resuspended in an YPD
liquid medium, and exposed to BN nanomaterials (160 and 800 mg/L) for 2 and 24 h. After
two washing steps with DPBS, cells were incubated in AcLi 2M for 2 min, washed and
incubated again for 2 min in a SDS (0.01%)-chloroform (0.4%) solution. Finally, the cells
supernatant was transferred to a black opaque 96-micro-well plate, and fluorescence was
measured with a Synergy-HT (BioTek, Winooski, Vermont, USA) microplate reader (excita-
tion, 485; emission, 528).
3.10. Statistics
Statistical analysis data are presented as means ± SD. The one-way analysis of variance
(ANOVA) was performed for multiple comparisons, followed by the Dunnet post hoc test.
Statistical tests were carried out using Prism 6.0 (GraphPad Prism, GraphPad Software,
Inc., San Diego, California, USA). p-values ≤ 0.05 were considered to indicate statistical
significance.
4. Conclusions
The results obtained in the present work provide novel insights on the physico-
chemical characteristics and the toxicological impact of commercial 2D BN nanomaterials
on different eukaryotic models. The morphological analyses of commercial nanopowder
and nanoplatelets determined a lateral size in the nanoscale range for both products,
while the analyses of their structure and stoichiometry through Raman spectroscopy
and XPS revealed characteristics in concordance with those of hexagonal BN (h-BN).
The exposure analyses performed in human lung adenocarcinomic cells and the yeast
S. cerevisiae indicated that both BN-PW and BN-PL have a low toxicological impact in the
studied conditions. No reduction in cellular viability, nor oxidative stress production could
be observed in exposed human cells, while minor effects were observed in exposed yeast
cells even in the presence of very high nanomaterials concentrations. These results support
the suitability of BN nanomaterials as 2D materials to develop future biomedical and
environmental applications. However, since the degree of nanomaterial purity, size, shape,
and thickness may have an influence on the biological response of different organisms,
further studies are still necessary to increase the knowledge on the toxicological potential
of other commercial nanoforms distinct to those studied in the present study, expanding as
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well the portfolio of model organisms tested, which will allow to enhance the knowledge
on the potential hazard of BN nanomaterials against humans and the environment.
Supplementary Materials: The following are available online at https://www.mdpi.com/1422-006
7/22/2/567/s1, Figure S1: Dynamic light scattering (DLS) analysis of BN-PW and BN-PL suspensions
in water, DMEM 1% FCS, and YPD, Figure S2: ROS production of A549 cells treated with different
concentrations of BN-PW and BN-PL, Figure S3: Oxidative stress (ROS) determination of S. cerevisiae
cells exposed to 160 and 800 mg L−1 of BN-PW and BN-PL, during 2 h and 24 h.
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